Lifestyle intervention can be effective when treating non-alcoholic fatty liver diseases
(NAFLD) patients. Weight loss decreases cardiovascular and diabetes risk and can also …

Traditionally, obesity and its related diseases have been considered a problem in Western
countries. However, in the past two decades, urbanisation in many Asian countries has led …

Since the publication of the guidelines for the assessment and management of non alcoholic
fatty liver disease (NAFLD) by the Asia–Pacific Working Party on NAFLD in 2007, 1 our …

Nonalcoholic fatty liver disease (NAFLD) is a disorder characterized by excess accumulation
of fat in hepatocytes (nonalcoholic fatty liver (NAFL)); in up to 40% of individuals, there are …

Background The bile acid derivative 6-ethylchenodeoxycholic acid (obeticholic acid) is a
potent activator of the farnesoid X nuclear receptor that reduces liver fat and fibrosis in …

Background & Aims Exercise is a first-line therapy for patients with non-alcoholic fatty liver
disease (NAFLD). We sought to: 1) summarize effective aerobic and resistance exercise …

Metabolic syndrome is defined by a constellation of interconnected physiological,
biochemical, clinical, and metabolic factors that directly increases the risk of cardiovascular …

The development of non-alcoholic fatty liver disease is closely linked to lifestyle factors,
namely excessive caloric intake coupled with reduced physical activity and exercise. This …

Lifestyle modifications focused on healthy eating and regular exercise are the primary
recommendations for patients with nonalcoholic steatohepatitis (NASH). However, for …

Obesity is associated with an increased risk of nonalcoholic fatty liver disease (NAFLD).
Steatosis, the hallmark feature of NAFLD, occurs when the rate of hepatic fatty acid uptake …